Dr. Reddy's and Nestlé Health Science Limited, a joint venture between Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; ... May 07
BioAsia, Asia’s premier life sciences and health-tech forum co-hosted by the Government of Telangana, is preparing to launch its 23rd edition on ... Feb 14
On track towards Vision 2030 Solid revenue growth of 17% on the back of Line 3 in CDMO sterile Injectables EBITDA margins to expand going ... Feb 06
Over time, as competition increases and supply chains become more efficient, patients could experience tangible benefits, particularly in specialised care settings.... Jan 29
As India continues to reform its medical education and regulatory systems, generic prescribing stands out as a test of sincerity.... Jan 15
A small inhaler may seem like a modest innovation, yet its implications reachs outward, touching behavior, psychology, and public health. ... Dec 26
India can strengthen its position as the pharmacy of the world without losing the heart of its domestic ecosystem. But if the shift becomes a ... Nov 15
As the patent clock ticks towards 2026, both Novo and Lilly are likely to intensify their efforts in expanding supply chains, boosting physician engagement, and ... Nov 14
Regulatory bodies must act with transparency, manufacturers must uphold integrity, and hospitals must maintain vigilance because behind every batch number is a child whose life ... Oct 18
In an industry where innovation often hides behind profit margins, Mankind’s bet on women’s health stands out as both a strategic and ethical ... Oct 16
The GST reforms of September 2025 could become a landmark in the ongoing effort to make healthcare more affordable and accessible.... Sep 16
Let it be a prompt to throttle up quality, not cut corners and to keep patient safety at centre, not supply speed.... Aug 18
Long-term effects of GLP-1 medications remain under investigation, and shifting to easy-to-use pens removes barriers but not risks.... Aug 16
FDA-approved injectables adds credibility in Africa, Latin America, and beyond. The ripple effect may elevate Indian pharmaceutical manufacturing from “copycat” to “crown-standard.”... Aug 16
States like Tamil Nadu show how bulk procurement and coordinated public pharmacy systems outperform piecemeal outlets.... Aug 11
Generic semaglutide could ultimately become not just an alternative, but the new standard driven by precision manufacturing, scaled access, and cost redefined.... Aug 11
India’s pharma strength was born of volume, value, and virtue. It supplied essential drugs when others hesitated and that legacy remains potent.... Aug 11
As more citizens choose affordability without compromising effectiveness, a stronger, healthier India begins to take shape.... Aug 06
India is stepping into a new phase of healthcare where the battle against obesity is no longer limited to gym memberships or diet fads.... Aug 01
China Medical System Holdings Limited on the Main Board of the Singapore Exchange ("SGX"), SGX and CMS co-hosted the "Singapore and Emerging Markets Pharmaceutical ... Jul 22
As India confronts an alarming rise in obesity and related conditions like type 2 diabetes, cardiovascular disease, and polycystic ovarian syndrome, the spotlight on medical ... Jun 25
Rivaroxaban under a generic label can significantly reduce treatment costs for patients, insurers, and government healthcare programs, all while maintaining the efficacy and safety standards ... Jun 03
With innovations like DeepDKD, the healthcare narrative could shift from reactive to preventive, from managing damage to averting it entirely.... May 08
The WHO's endorsement of GLP-1 receptor agonists represents a significant development in the global fight against obesity.... May 08
... Mar 24
-Advertisements-
.jpeg)
Wednesday, July 29, 2026
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpeg)
.jpg)
.jpg)
.jpg)
.jpeg)
